Globus Medical acquires Synoste

Globus Medical has acquired Synoste, a Norway-based orthopaedic bone lengthening technology spinout of Aalto University. The deal enables specialty chemicals producer Evonik to exit.

“Synoste, a Norway-based orthopaedic bone lengthening technology spinout of Aalto University, has been acquired by medical device manufacturer Globus Medical in a deal enabling specialty chemicals producer Evonik to exit.”globalventuring.com

• 2 sources
• globalventuring.comGlobus absorbs Synoste - Global VenturingCallum CyrusOct 27, 2020
• investorsinhealthcare.comFinland: Globus Medical goes out on a limb for Synoste - Investors in HealthcareAdrian MurdochOct 28, 2020

Summarized from public sources; check the original articles before acting on it.